<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-pathogens-09-00519">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rubbert-Roth</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Furst</surname>
    <given-names>D.E.</given-names>
   </name>
   <name>
    <surname>Nebesky</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Jin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Berber</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>A review of recent advances using tocilizumab in the treatment of rheumatic diseases</article-title>
  <source>Rheumatol. Ther.</source>
  <year>2018</year>
  <volume>5</volume>
  <fpage>21</fpage>
  <lpage>42</lpage>
  <pub-id pub-id-type="doi">10.1007/s40744-018-0102-x</pub-id>
  <pub-id pub-id-type="pmid">29502236</pub-id>
 </element-citation>
</ref>
